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Abstract
Background: Besides functioning as chemosensors for a broad range of endogenous and synthetic ligands,
transient receptor potential vanilloid (TRPV) 1–4 channels have also been related to capsaicin (TRPV1), pain, and
thermal stimuli perception, and itching sensation (TRPV1–4). While the expression of the TRPV1–4 genes has
been adequately proved in skin, sensory fibres and keratinocytes, less is known about TRPV3 and TRPV4
expression in human blood cells.
Results: To study the gene expression of TRPV1–4 genes in human leukocytes, a quantitative Real-Time PCR
(qRT-PCR) method, based on the calculation of their relative expression, has been developed and validated. The
four commonly used house-keeping genes (HKGs), β-Actin (Act-B), glyceraldehyde-3P-dehydrogenase (GAPDH),
hypoxanthine ribosyltransferase (HPRT1), and cyclophilin B (hCyPB), were tested for the stability of their
expression in several human leukocyte samples, and used in the normalization procedure to determine the mRNA
levels of the TRPV 1–4 genes in 30 healthy subjects. cDNAs belonging to all the TRPV1–4 genes were detected
in leukocytes but the genes appear to be expressed at different levels. Our analysis did not show significant sex
differences in TRPV1–4 cDNA levels in the 30 healthy subjects. The same qRT-PCR assay was used to compare
TRPV1–4 expression between healthy controls and patients hyposensitive to capsaicin, pain and thermal stimuli:
an almost doubled up-regulation of the TRPV1 gene was found in the pathological subjects.
Conclusion: The qRT-PCR assay developed and tested in this study allowed us to determine the relative
expression of TRPV1–4 genes in human leukocytes: TRPV3 is the least expressed gene of this pool, followed by
TRPV4, TRPV1 and TRPV2. The comparison of TRPV1–4 gene expression between two groups of healthy and
hyposensitive subjects highlighted the evident up-regulation of TRPV1, which was almost doubly expressed (1.9×
normalized fold induction) in the latter group. All the four house-keeping genes tested in this work (Act-B,
GAPDH, hCyPB, HPRT1) were classified as optimal controls and showed a constant expression in human
leukocytes samples. We recommend the use of these genes in similar qRT-PCR studies on human blood cells.
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Background
Transient receptor potential (TRP) channels have been
identified as cellular sensors that respond to diverse exter-
nal and internal stimuli and play a fundamental role in
the cytosolic free Ca2+ concentration, either by acting as
Ca2+  entry pathways in the plasma membrane or via
changes in membrane polarization [1].
The transient receptor potential vanilloid (TRPV) sub-
family consists of the six mammalian members TRPV1–
TRPV6 [2]. TRPV1–4 genes are related to thermal pain
and/or warm sensing; in particular, TRPV1 is related to
capsaicin, noxious temperature, pain perception, bladder
distension and inflammation-induced thermal hyperalge-
sia [1,3]. Thermal sensation at high temperatures seems to
be exclusively related to TRPV2 [4]. TRPV4 is also thought
to play a fundamental role in nociception, osmosensing,
warm sensing nociception and pressure sensing [2]. In the
same vanilloid TRP gene subfamily, the TRPV5 and 6
genes are mainly involved in calcium re-absorption in the
kidney and absorption in the duodenum [5].
In humans, disease-related changes in TRPV1 expression
have been described in inflammatory bowel disease, irri-
table bowel syndrome, cervical cancer and destrusor
hyperreflexia [6-9]. As a result, altered TRPV gene expres-
sion could play a role in the molecular diagnosis of vari-
ous disease states. In particular, according to the proposed
functions of TRPV1–4, these genes seem to play a funda-
mental role in breast and prostate cancer, myasthenic syn-
drome, non-insulin-dependent diabetes mellitus, central
hypoventilation syndrome and cardiopathy (see [1] for a
review). Abnormal regulation of ion channel function is
especially interesting in all forms of inflammation and in
systemic diseases [1].
For years, there was a general consensus that the expres-
sion of TRPV1 was restricted to sensory afferent neurones
and discrete areas of the central nervous system. Later,
however, the expression of this gene was also detected in
a variety of non-neuronal tissues, including the bladder
and urethral epithelium, bowel, lung, kidney, spleen,
stomach, heart, oesophagus, neutrophil granulocytes,
myocytes, and mast cells [10-13]. More recently, the
expression of TRPV1 and 2 has also been detected in
human peripheral blood cells (PBCs) [3]. The physiologi-
cal role of TRPV1–2 genes in PBCs has yet to be deter-
mined, but it has been hypothesized that, under
pathological conditions, their up-regulation may be an
indicator of inflammation at a secondary site [3].
To study the roles of TRP channels in cells and tissues, it is
important to know where and at what level they are
expressed. For valid data on the specific expression in tis-
sues, it is important to test gene expression by several
independent techniques [14]. qRT-PCR is one of the most
reliable and effective methods for the quantification of
variations in mRNA expression, but the reliability of the
results is strictly dependent on a careful experimental
design, including the use of appropriate controls in the
data normalization step [15-17]. Both absolute quantifi-
cation and relative quantification procedures could lead
to severe misinterpretation of the results if not preceded
by preliminary evaluations of the house-keeping genes
(HKGs) [17-20].
Unfortunately, our knowledge of the detailed mecha-
nisms through which TRP channels function is still ele-
mentary and this situation hampers our understanding of
the mechanistic role of these genes in human disease; the
more we learn about the basic physiology of TRP channels
and their potential role in disease, the closer we will come
to the development of novel therapies for various disease
states [2]. In this study, besides developing a Sybr Green
qRT-PCR method based on a relative expression approach
with accurately selected control genes, we quantify
TRPV1–4 cDNA levels in human leukocytes by a compar-
ison between 30 healthy subjects and a family with a
peculiar form of hyposensitivity to pain, capsaicin and
thermal stimuli.
Results and discussion
Real-Time amplifications
The primer pairs used to amplify the genes of interest
(GOIs) (TRPV1–4) and the two HKGs (HPRT1 and
hCyPB) were newly developed in this study and were
accurately tested for their efficiency and reproducibility
using serial 1:3 dilutions of the same template cDNA
(Table 1). The oligonucleotides used to amplify the
remaining two HKGs, Act-B and GAPDH, were taken from
[21] and were checked before final acceptance on the basis
of their reliability.
All the primer pairs used in this study show good overall
efficiency and excellent reproducibility of the amplifica-
tion reactions (Table 1).
Evaluation of the stability of the selected HKGs
To ensure correct normalization of the expression levels
for the GOIs, the stability of the four control genes was
statistically determined using the two VBA applets,
geNorm and NormFinder [22] (Table 2). According to these
two softwares, the four HKGs tested in this study show
optimal overall reliability, confirmed by the extremely
low "M" values (geNorm) and Stability Values
(NormFinder) (Table 2). Therefore, all the HKGs were
retained in the calculation of the normalization factor
using REST2005 [23]. In particular, geNorm  classifies
GAPDH and Act-B as the best two controls of the group
(Table 2), while the best position in the stability rankingMolecular Pain 2008, 4:51 http://www.molecularpain.com/content/4/1/51
Page 3 of 10
(page number not for citation purposes)
produced by NormFinder is occupied by Act-B, followed
by hCyPB, GAPDH and HPRT1 (Table 2). Moreover,
geNorm suggests that an accurate normalization factor of
qRT-PCR data can be calculated using only the two most
stable HKGs (Act-B and GAPDH) with no further need to
include additional controls in the analysis. As shown in
Table 2, the addition of further HKGs will not signifi-
cantly affect the reliability of the determined normaliza-
tion factor, yielding V2/3  and V3/4  values (pair-wise
variation between two sequential normalization factors)
of 0.04 and 0.05 respectively, well below the default cut-
off value of 0.15 [17]. The same analysis was repeated to
evaluate the stability of the selected control genes in the
group of pain insensitive subjects. Despite the poor statis-
tical relevance of the results, due to the low number of
samples included in this subanalysis, we obtained almost
identical outcomes in the stability rankings of the selected
controls, characterized by extremely low values of average
expression stability for each gene.
TRPV1–4 gene expression in leukocytes
The TRPV1–4 genes showed different expression patterns
in leukocyte samples from the 30 healthy donors. TRPV3
was classified as the least expressed gene of the pool, fol-
lowed by TRPV1 and TRPV4 (respectively 2.28 and 4.83
times more expressed than TRPV3). TRPV2 was by far the
most expressed one (approximately 89.361 times more
than TRPV3) (Fig. 1). The ratios of the TRPV1–4 gene
expressions in the samples are summarized in Fig. 2. Each
of the results presented in this section was confirmed by a
p  value < 0.001, calculated by REST2005. Despite the
highly significant difference between mean expressions of
the TRPV1–4 genes, our analysis is characterized by a
broad variation of the standard errors. Considering that
the blood samples analyzed in this study were checked for
the amount of lymphocytes T and B by cytofluorimetric
analysis, the broad variation in the standard error meas-
urements could be due both to a different composition of
samples between different cell subpopulations (neu-
trophils, eosinophils, basophils, monocytes, or macro-
phages), that could express at different levels the TRPV1–
4 genes, or to variations in the expression levels in the
same subpopulation.
TRPV1–4 gene expression in healthy subjects
To evaluate possible sex differences, we compared the
TRPV1–4 gene expression data for the men (n = 15) and
women (n = 15) belonging to the control group of healthy
subjects. None of the genes showed a significant differ-
Table 1: Details of primers and amplicons for the 4 HKGs and the 4 GOIs analysed in this study.
Gene Acc. Number Forward Primer 
Sequence [5'→3']
Position 
in cDNA
Reverse Primer 
Sequence [5'→3']
Position 
in cDNA
Amplicon 
Length
E% R2
Act-B* NM_001101 CTGGAACGGTGAAG
GTGACA
6th AAGGGACTTCCTGT
AACAATGCA
6th 140 bp 96.6 0.99
GAPDH* NM_002046 TGCACCACCAACTG
CTTAGC
7th GGCATGGACTGTGG
TCATGAG
7th/8th 87 bp 91.8 0.998
HPRT1 NM_000194 AGATGGTCAAGGTC
GCAAG
6th GTATTCATTATAGTC
AAGGGCATATC
8th 128 bp 104.2 0.995
hCyPB M60857 CCAACGCAGGCAAA
GACACCAA
4th GCTCTCCACCTTCC
GCACCA
5th 131 bp 91.2 0.995
TRPV1 NM_080704 GGCTGTCTTCATCAT
CCTGCTGCT
12th GTTCTTGCTCTCCT
GTGCGATCTTGT
12th 117 bp 94.2 0.99
TRPV2 NM_016113 CTTCCTTTTCGGCTT
CGCTGTAG
10th GCACTGACTCTGTG
GCATTGG
11th 95 bp 89.7 0.99
TRPV3 NM_145068 TCCTCACCTTTGTTC
TCCTCCT
14th CGCAAACACAGTCG
GAAATCAT
15th 211 bp 103.6 0.995
TRPV4 NM_021625† 
NM_147204‡
CTACGCTTCAGCCCT
GGTCTC
11th/12th† GCAGTTGGTCTGGT
CCTCATTG
13th † 76 bp 103.7 0.99
* refers to RT-PCR primers taken from [21]. † refers to TRPV4 isoform a and ‡ to TRPV4 isoform b.
Table 2: Stability ranking of the candidate reference genes calculated by geNorm and NormFinder and V values calculated by 
geNorm.
Ranking V value
Software 1st 2nd 3rd 4th V2/3 V3/4
geNorm (Average M value) Act-B/GAPDH* (0.013) hCyPB (0.016) HPRT1 (0.017) 0.005 0.004
NormFinder (Average Stability Value) Act-B (0.007) hCyPB (0.008) GAPDH (0.009) HPRT1 (0.010) Not determined Not determined
* means that 1st and 2nd positions cannot be further ranked by geNorm.Molecular Pain 2008, 4:51 http://www.molecularpain.com/content/4/1/51
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ence in expression between males and females (TRPV1 p =
0.1; TRPV2 p = 0.5; TRPV3 p = 0.7; TRPV4 p = 0.07).
Moreover, to evaluate the possible effects of hormonal
changes during the menstrual cycle, we divided the 15
healthy females into two groups: those in the "follicular
phase" (8 subjects) and those in the "luteal phase" (7 sub-
jects). Also in this case, the TRPV1–4 expression did not
differ significantly between the two groups (TRPV1 p =
0.9; TRPV2 p = 0.6; TRPV3 p = 0.4 TRPV4 p = 0.3).
TRPV1–4 gene expression differences between healthy and 
hyposensitive subjects
Interestingly, the statistical analysis of the TRPV1–4 gene
expression differences between healthy donors (n = 30)
and subjects hyposensitive to painful thermal stimuli and
capsaicin stimulation (n = 5) showed that TRPV1 gene
expression was almost doubled in the hyposensitive
patients (mean induction factor of TRPV1 is 1.9; p =
0.023; Standard Error range 1.017–3.540; Table 3). How-
ever, the TRPV2–4 gene expression did not differ signifi-
cantly between the two groups (Table 3).
Conclusion
In the present study, we demonstrated that the TRPV1–4
genes are expressed in human leukocytes. While the rates
of expression were not influenced by gender, we found
significant differences for TRPV1 between healthy subjects
and patients hyposensitive to painful thermal and capsai-
cin stimulation.
The genes belonging to the transient receptor potential
(TRP) family, and in particular the members of the TRPV
subfamily, are known to be involved in cell responses to
internal and external environmental factors, including
osmolarity, pressure, heat, cold, hormones and inflam-
matory mediators [11]. Blood is of particular interest
among the non-nervous biological material because of its
involvement in immune and inflammatory processes and
its role in the distribution of circulating signals (cytokines,
hormones). A recent study demonstrating TRPV1–2 gene
expression in human peripheral blood cells by means of
qRT-PCR and immunocytochemical techniques [3],
stressed the importance of further studies to clarify the
physiological and pathophysiological role and regulation
of TRPV channels in human mononuclear cells. In this
context, our work constitutes an additional effort to inves-
Relative expression of the TRPV1–4 genes in human leukocytes from healthy subjects (n = 30) Figure 1
Relative expression of the TRPV1–4 genes in human leukocytes from healthy subjects (n = 30). Relative expres-
sion measurements of the TRPV1–4 genes using qRT-PCR calculated using REST2005 (relative expression software tool). Fold 
change (y axis) represents the relative expression of the TRPV1, TRPV2 and TRPV4 genes in comparison to TRPV3 (least 
expressed gene of this pool and therefore considered equal to 1), normalized by Act-B, GAPDH, hCyPB and HPRT1 reference 
gene expressions. Expression standard errors are expressed within brackets at the top of each bar. * means p < 0.001.Molecular Pain 2008, 4:51 http://www.molecularpain.com/content/4/1/51
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tigate the presence and relative amounts of TRPV1–4 gene
transcripts in human leukocytes.
For this purpose, we decided to test and validate our Sybr
Green qRT-PCR assay based on the relative quantification
of TRPV1–4 gene transcripts. While absolute quantifica-
tion (based on external standards) is the method of choice
for nucleic acid quantification, relative quantification is
based on the expression levels of one or more target genes
versus one or more reference genes and, in many experi-
ments, is adequate for investigating physiological changes
in gene expression levels [17,24]. The normalization pro-
cedure should be considered mandatory in qRT-PCR stud-
ies and the importance of the choice of the most stably
expressed HKGs is too often underestimated during qRT-
PCR assays, easily leading to misinterpretation and low
reproducibility of the final results. Therefore, we decided
to validate, up to their expression stability, four of the
most widely used house-keeping genes in human leuko-
cyte samples from the 30 healthy donors, equally divided
between males and females. Amplicon lengths and specif-
icity, and PCR amplification efficiencies and reproducibil-
ity, were accurately checked, and the stability of the
selected control gene expressions among samples was
analysed with two widely used softwares, namely geNorm
and NormFinder. All four house-keeping genes considered
in this study (Act-B, GAPDH, hCyPB, HPRT1) were classi-
fied as optimal controls and showed stable expression in
human leukocytes samples. We recommend the use of
these genes for similar qRT-PCR studies and we hope that
our outcomes will help to draw up a preliminary "univer-
Reciprocal expression levels of TRPV1–4 genes in human leukocytes from healthy donors (n = 30) Figure 2
Reciprocal expression levels of TRPV1–4 genes in human leukocytes from healthy donors (n = 30). Expression 
rates of TRPV1–4 genes calculated using qRT-PCR with relative quantification analysis using REST (relative expression software 
tool). Fold changes represents the reciprocal relative expression of the TRPV1–4 mRNA in physiological conditions in the 30 
healthy donors. Values below (above) the diagonal line of each cell refer to the expression levels of genes on the y-axis (x-axis) 
compared to those of the corresponding genes on the x-axis (y-axis); S.E. means Expression Standard Error as calculated by 
the software REST; all p values are below 0.001.
Table 3: TRPV1–4 relative expression measure comparisons between the group of subjects affected by hyposensitivity to capsaicin, 
pain and thermal stimuli and the group of healthy controls.
Gene Normalized Fold Expression Expression Standard Error P value
TRPV1 1.9 1.017 – 3.540 0.023*
TRPV2 0.9 0.592 – 1.474 0.941
TRPV3 1.6 0.391 – 6.803 0.23
TRPV4 1.5 0.746 – 3.084 0.123
Data are given as normalized fold expression, indicating the relative quantification of the qRT-PCR signal detected in hyposensitive subjects (n = 5) 
in relation to that detected in healthy donors (n = 30). Note that the significance (*) for the TRPV1 gene indicates an up-regulation in subjects 
affected by hyposensitivity to capsaicin, pain and thermal stimuli.Molecular Pain 2008, 4:51 http://www.molecularpain.com/content/4/1/51
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sal protocol" for a better comparison of qRT-PCR results
from different studies on human blood cells.
In addition to proving the presence of TRPV1–4 cDNAs in
human leukocytes, our qRT-PCR assay revealed a lack of
significant differences in TRPV1–4 expression between
healthy males (n = 15) and females (n = 15), and between
females sampled during the luteal and follicular phases of
the menstrual cycle. This partially contrasts with experi-
mental data concerning the effect of estrogens on the
expression of the TRPV genes. For instance, the TRPV1
expression in viscera was found to be increased by estra-
diol administration in female rats [25], a pattern that
seems not to be confirmed in our experiments on human
leukocyte samples. Therefore, the physiological hormonal
differences between women in the two menstrual phases,
as well as the hormonal differences between the sexes,
failed to affect TRPV1–4 gene expression, suggesting a
negligible influence of gonadal hormones on the hae-
matic expression of the TRPV subfamily genes, at least in
healthy human subjects.
Additionally, the qRT-PCR assays allowed us to determine
the relative expression of TRPV1–4 genes in human leuko-
cytes. While the presence of TRPV1–2 transcripts in
human blood cells was recently reported, our study is the
first to demonstrate TRPV3–4 expression in human leuko-
cytes. According to the results for the 30 healthy donors,
we can conclude that TRPV3 is the least expressed gene of
this pool, followed by TRPV4, TRPV1 and TRPV2 (Fig. 1).
Compared to TRPV3, the TRPV4, TRPV1 and TRPV2 genes
showed a physiological normalized fold expression of
2.2×, 4.8× and 89.3×, respectively. The outcomes of our
analysis (Fig. 2) are in partial agreement with the data
reported by [3], where a ≈150-fold over-expression of
TRPV2 compared to TRPV1 is shown. Although substan-
tially reducing the gap between the expression of the two
genes, our results confirm this trend: the TRPV1 cDNA lev-
els are 18.4-fold lower than those of TRPV2.
The comparison of TRPV1–4 gene expression between
healthy subjects (n = 30) and the hyposensitive group (n
= 5) highlighted the evident up-regulation of TRPV1,
which was almost doubly expressed (1.9× normalized
fold induction) in the latter group (Table 3). TRPV1 is by
far the best understood TRP channel [1] and both in vivo
and in vitro studies have repeatedly shown that these
receptors (TRPV1–4) are involved in the transmission of
pain and/or thermal stimuli and capsaicin sensation
[26,27]. In particular, TPRV1 gene transcription produces
an mRNA coding for a protein devoted to the vanilloid
receptor 1; it is recognized as a molecular integrator of
inflammatory mediators and is thought to mediate
peripheral sensitization, involving a reduced threshold of
activation and an increased responsiveness of peripheral
nociceptors [28-31].
On the basis of these findings, the higher TRPV1 expres-
sion, related to the influence of TRPV genes in the
immune response of lymphocytes, might be caused by the
more frequent inflammatory and infectious processes in
these patients due to their hyposensitive status. Under
pathological conditions, the up-regulation of TRPV1
could be an indicator of inflammation at a secondary site
related to the influence of TRPV1 on the release of neu-
ropeptides that can up-regulate the expression of adhe-
sion molecules in endothelial cells and consequently
activate T-cells [3].
The up-regulation of TRPV1 in pain-insensitive subjects
may also be linked to its polymorphism [32,33] or to
some functional anomalies of this gene [34] that may be
associated with pain perception.
Two recent publications focused on the functional effects
of nonsynonymous polymorphism in the human TRPV1
gene and on the genetic influence on variability in human
pain sensitivity [32,33]. TRPV1 presents five nonsynony-
mous polymorphisms expected to result in nonconserva-
tive amino acid substituitions [33]. While TRPV1WT and
its variant forms show similar EC50 for capsaicin, HEK293
cells transfected with TRPV1P91S and TRPV1I315M variants
exhibit enhanced responsiveness to a second TRPV1 ago-
nist, named anandamide [33]. An additional sixth single
nucleotide polymorphism, predicted to reside within
membrane-spanning helix five, seems to be responsible
for a conservative amino acid substitution (TRPV1I585V)
that could alter receptor structure/function during cold
perception [32], increasing sensitivity to cold-induced
pain in American females subjects. This observation is
apparently in contrast with the previously reported in
vitro normal functional response to agonists of the
TRPV1I585V variant [33,35]. In the heterologous expres-
sion model described in [33], the two allelic variants
TRPV1I315M and TRPV1P91S resulted in markedly increased
abundance of the variant TRPV1 protein, although with a
very modest increment in the mRNA levels; the authors
suggest that disease state is mediated through altered
expression of a normal protein and that much of the inter-
subject phenotypic variation will be encoded by polymor-
phisms that influence levels of gene expression.
A TRPV1 splice variant lacking Exon 7 (named TRPV1b)
was previously cloned from human dorsal root ganglia
[34], showing that recombinant TRPV1b was not activated
by capsaicin (1 microM), protons (pH 5.0) or heat (50
degrees C). When co-expressed with TRPV1, TRPV1b
formed complexes with TRPV1, and dose-dependently
inhibited TRPV1 channel function in response to capsai-Molecular Pain 2008, 4:51 http://www.molecularpain.com/content/4/1/51
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cin, acidic pH, heat and endogenous vanilloids. These
data support the hypothesis that TRPV1b is a naturally
existing inhibitory modulator of TRPV1 and that mutual
regulation between TRPV1 and TRPV1b might take place
in the same neuronal cell in vivo. Therefore, in hyposensi-
tive subjects, the up-regulation of TRPV1b could lead to
pathological inhibition of TRPV1 activity, with a conse-
quent loss of the natural ability to perceive thermal, pain
and capsaicin stimulation. Other authors [34] did not
exclude the possibility that TRPV1b may be up-regulated
under physiological or pathological conditions. Since the
qRT-PCR method described in this study does not allow
discrimination between cDNAs transcribed from the
TRPV1 gene or the recombinant TRPV1b splice variant,
further studies are required to clarify the potential role of
the TRPV1b splice variant and to quantify its expression in
tissues of hyposensitive subjects.
It is evident that the presence of the TRPV1 splice variant
or of genetic polymorphism associated with this gene,
may provide another mechanism for down-regulating
channel activity, and the more we learn about fundamen-
tal TRP channel physiology and the potential role of TRPs
in disease, the closer we will come to the development of
novel therapies for various disease states.
Methods
Healthy subjects
The control group of 30 healthy volunteers consisted of
15 men (mean age 35.0, range 25–45 years) and 15
women (mean age 33.3, range 22–46 years). Subjects
were asked to fill in a short questionnaire regarding their
general state of health and, in particular, their sensitivity
to painful thermal stimuli and capsaicin perception. For
the women, the menstrual cycle phase was recorded and
considered in the analysis as follicular (1st–14th day) or
luteal (15th–28th  day). Written informed consent was
obtained from all subjects.
Hyposensitive subjects
This sample consisted of five subjects previously diag-
nosed as suffering from hyposensitivity to painful thermal
and capsaicin stimulation. The subjects, belonging to the
same family (3 women and 2 boys from 3 generations),
were a 75-year-old woman, her two daughters (40-year-
old and 34-year-old sisters) and two nephews (two broth-
ers, 14 and 11 years old). All these subjects were appar-
ently healthy, with normal mental performance and high
performance in physical activities, with an apparently nor-
mal quality of life. The main clinical data were: absence of
pain in response to usual painful stimuli (all subjects),
low sensitivity to capsaicin (all subjects), history of clini-
cal autonomic disability plus several episodes of hyper-
thermia, increased warm and cold thresholds, recurrent
infections (3 subjects), absence of corneal reflex (all sub-
jects), rare episodes of orthostatic hypotension (3 sub-
jects). Written informed consent was obtained from the
adults and from the parents of the two children; oral con-
sent was also obtained from the participating children.
RNA isolation
Peripheral blood (3 ml) was collected in sterile tubes from
the 30 healthy donors (15 males, 15 females) and the five
patients affected by PTCH. Cytofluorimetric analysis of
samples revealed a marked uniformity of lymphocytes T
and B populations. The markers CD3 and CD19 were
respectively used to detect lymphocytes T and B. Heparin
was used to stabilize the samples and cellular RNA was
immediately isolated from whole blood (1.5 ml) using
the QIAamp RNA Blood Mini Kit (Qiagen). A DNase on-
column treatment was performed during the RNA isola-
tion procedure to avoid genomic DNA (gDNA) carryovers
(RNase-Free DNase Set, Qiagen). The concentration and
purity of all RNA samples, eluted in a final volume of 35
μl RNase-Free water (Qiagen), were determined with a
Nano-Drop® ND-1000 UV-Vis Spectrophotometer (Nano-
Drop Technologies). Based on the absorbance ratio at
260/280 nm and at 230/260 nm, all samples were pure
and free of protein and organic pollutants derived from
the RNA isolation procedure. The overall sample integrity
was confirmed by denaturing formaldehyde agarose gel
(1.2%) electrophoresis and ethidium-bromide staining,
showing sharp and intense 18S and 28S ribosomal RNA
bands with a total absence of smears. Samples were stored
at -80°C until use.
Reverse transcription
To avoid any genomic DNA contamination during qRT-
PCR, retrotranscription of 600 ng total RNA was per-
formed with the QuantiTect Reverse Transcription Kit
(Qiagen), according to the manufacturer's instructions.
This kit ensures complete digestion of genomic DNA by a
brief incubation of the sample at 42°C with a specific
Wipeout buffer before retrotranscription. For each of the
30 samples, 1 μl of total RNA was collected prior to the
retrotranscription step and stored at -80°C. RNA samples
were subsequently used in Real-Time PCR, as internal
controls to check for potential gDNA contamination.
Design of RT-PCR primers
Real-Time PCR primers used to amplify the two control
genes, β-actin and GAPDH, were taken from [21].
Nucleotide sequences of the four genes of interest (GOIs)
and the remaining two house-keeping genes (HKGs;
HPRT1 and hCyPB) were downloaded from GenBank files
under the Accession Numbers specified in Table 1 and
specific exon-intron boundaries were identified. PCR
primers for real-time assays were designed using Beacon
Designer 2.06 (Premier Biosoft International) giving spe-Molecular Pain 2008, 4:51 http://www.molecularpain.com/content/4/1/51
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cial attention to primer length, annealing temperature,
base composition and 3'-end stability. To ensure optimal
DNA polymerization efficiency, the amplicon length
ranged between 76 and 211 bp (Table 1). All the RT-PCR
primer pairs used in this study span exon-exon junctions
or are located on different exons, with the exceptions of
those for the TRPV1 and Act-B genes (Table 1). TRPV4
primers were specifically designed to amplify a short
amplicon located in proximity to the 3' end of the cDNA,
shared between the two described splice variants, isoform
a (GenBank accession number NM_021625) and isoform
b (NM_147204). During preliminary qRT-PCR assays, the
optimal primer concentration was determined for each
primer pair: it generated the lowest Ct value and a sharp
peak, with no amplification of non-specific products or
primer-dimer artifacts. For each pair of primers, the effi-
ciency of qRT-PCR (E), the slope values and the correla-
tion coefficients (R2) were determined, using serial 1:3
dilutions of template cDNA, on a iQ5 machine (Bio-Rad)
(Table 1). Products were subsequently run on 2% agarose
gel to check for size specificity and eventually sequenced.
Real-Time PCR
Real-time amplifications, using SYBR Green detection
chemistry, were run in triplicate on 96-well reaction plates
with the iQ5 machine (Bio-Rad). Reactions were prepared
in a total volume of 20 μl containing: 0.8 μl cDNA, 0.6 μl
of each 10 μM primer (300 mM each; Invitrogen), 10 μl of
iQ™ SYBR® Green Supermix (Bio-Rad) and 8 μl RNase/
DNase-free sterile water (Qiagen). Blank controls were
run in triplicate for each master mix. The cycle conditions
were set as follows: initial template denaturation at 95°C
for 1 min, followed by 40 cycles of denaturation at 95°C
for 10 s, and combined primer annealing/elongation at
60°C for 30 s, as described in [36]. This cycle was fol-
lowed by a melting curve analysis, ranging from 56°C to
95°C, with temperature increasing by steps of 0.5°C every
10 s.
Baseline and threshold values were automatically deter-
mined for all plates using the Bio-Rad iQ5 Software 1.0. In
order to ensure comparability between data obtained
from different experimental plates, the threshold value
was subsequently manually set to the value corresponding
to the arithmetic mean between the automatically deter-
mined thresholds annotated previously; then all data were
reanalyzed. Raw Ct values (See additional file 1: Raw Ct
values table) were transformed to quantities using an
Excel spreadsheet generated by the authors, based on the
comparative Ct method. The resulting data were con-
verted into correct input files, according to the require-
ments of the software, and analysed using the Excel
spreadsheet REST2005 [23] and the VBA applet geNorm
[17].
Reliability of the HKGs
To ensure correct normalization of the expression levels
for the GOIs, the stability of the four control genes was
statistically determined using the two VBA applets geNorm
[17] and NormFinder [22] (Table 2). geNorm provides a
ranking of the tested genes based on their expression sta-
bility, determining the two most stable HKGs or a combi-
nation of multiple stable genes for normalization.
Selected HKGs are ranked according to the determined
control gene-stability measure (M, average pair-wise vari-
ation of a particular gene with all other control genes),
from the most stable (lowest M values) to the least stable
(highest M values) [17,37]. In addition, assessment of the
normalization factor allows identification of the optimal
number of control genes.
NormFinder is another VBA applet based on an algorithm
for identifying the optimal normalization gene(s) among
a set of candidates. It ranks the set of candidate genes
according to their expression stability value in a given
sample set and a given experimental design [22].
REST2005 analysis
REST2005 is a software tool based on qRT-PCR raw data
which allows a relative quantification between two sam-
ple groups and subsequently tests the significance of the
results with a suitable statistical model [23]. This software
determines whether there is a significant difference
between two groups of samples, taking into account issues
of reaction efficiency and reference gene(s) normalization
and using randomisation techniques. In this study,
REST2005 was specifically used to compare the expression
levels of the TRPV1–4 genes in whole blood samples (nor-
malized using the 4 HKGs previously analyzed by geNorm
and  NormFinder) of various groups: (i) two groups of
healthy subjects consisting of 15 males and 15 females;
(ii) two groups of females in the luteinic (n = 7) and fol-
licular (n = 8) phase of the menstrual cycle; (iii) healthy
(n = 30) and hyposensitive (n = 5) subjects. The same soft-
ware was also used to calculate relative expression levels
of the TRPV1–4 genes for all the healthy donors (n = 30).
Statistical analysis of gene expression was based on an
hypothesis test performing 50,000 random reallocations
of samples (hyposensitive subjects) and controls (healthy
subjects). The mathematical model used was based on the
correction for exact PCR efficiencies and the mean cross-
ing point deviation between sample group(s) and control
group(s). Subsequently, the expression ratio results of the
investigated transcripts were tested for significance by a
Pair Wise Fixed Reallocation Randomisation Test and
plotted using standard error (SE) estimation via a com-
plex Taylor algorithm [23]. Samples with a probability
value of < 0.05 were considered significantly different
between the groups.Molecular Pain 2008, 4:51 http://www.molecularpain.com/content/4/1/51
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